NNPTE
SLNO

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Soleno Therapeutics SLNO Stock Holding History

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-502,374
Closed -$42.1M – 57
2025
Q2 		$42.1M Buy
+502,374
New +$37.6M 4.97% 5
2025
Q1 		– Sell
-299,244
Closed -$13.5M – 57
2024
Q4 		$13.5M Buy
+299,244
New +$15.5M 1.63% 28

Other funds holding SLNO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's SLNO Position: Q3 2025 in Review

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold out of Soleno Therapeutics (SLNO) in Q3 2025, closing a stake of 502,374 shares — an estimated $42.1M sold.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in SLNO in Q4 2024 and held it in 2 quarters. The position peaked at $42.1M in Q2 2025. 240 funds tracked by Wall St. Rank hold SLNO as of Q3 2025.

  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne reported no remaining Soleno Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold 502,374 Soleno Therapeutics shares in Q3 2025, an estimated $42.1M.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in Soleno Therapeutics in Q4 2024 and held it in 2 quarters.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's Soleno Therapeutics position peaked at $42.1M in Q2 2025.
  • 240 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q3 2025.

Based on Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's 13F filing for Q3 2025, filed 12 Nov 2025.